ARID2 mutations were enriched in clusters 1–2 with greater methylation changes, and a previous study in hepatocellular carcinoma indicates that ARID2 could recruit DNMT1 to the promoter, which increased promoter methylation [51]. This evidence concerns the gene DNMT1 and hepatocellular carcinoma.